Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter de Heer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Anticancer Research|December 1, 2022
The Prognostic Value of Plasma Small Extracellular Vesicles' Phenotype in Patients With Gastrointestinal Stromal TumorCharlotte M Brinch, Estrid Hogdall, Pieter DE Heer, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 2, 2021
Assessment of sarcopenia in patients with upper gastrointestinal tumors: Prevalence and agreement between computed tomography and dual-energy x-ray absorptiometryCasper Simonsen, Thomas S Kristensen, Anna Sundberg, et al.
Cancer Chemotherapy and Pharmacology|February 6, 2008
Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancerPieter de Heer, Maro H Sandel, Gunther Guertens, et al.
Acta Oncologica (Stockholm, Sweden)|January 31, 2019
Exercise-mediated improvement of depression in patients with gastro-esophageal junction cancer is linked to kynurenine metabolismAnita Herrstedt, Marie L Bay, Casper Simonsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancerMichiel F G de Maat, Cornelis J H van de Velde, Naoyuki Umetani, et al.
The Lancet Regional Health. Europe|August 13, 2025
Nasogastric tube after oesophagectomy and risk of anastomotic leak: a Nordic, multicentre, open-label, randomised, controlled, non-inferiority trialJakob Hedberg, Joonas Kauppila, Eirik Kjus Aahlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Caspase-3 activity predicts local recurrence in rectal cancerPieter de Heer, Elza C de Bruin, Elma Klein-Kranenbarg, et al.
EJNMMI Research|June 6, 2025
Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancersRuben D Houvast, Vincent Q Sier, Maurice van Duijvenvoorde, et al.
Clinical Nutrition ESPEN|January 14, 2024
The impact of high versus standard enteral protein provision on functional recovery following intensive care admission: Protocol for a pre-planned secondary Bayesian analysis of the PRECISe trialSamuel Heuts, Pieter de Heer, Andrea Gabrio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2007
Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapyPieter de Heer, Marleen J E M Gosens, Elza C de Bruin, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Anticancer Research|December 1, 2022
The Prognostic Value of Plasma Small Extracellular Vesicles' Phenotype in Patients With Gastrointestinal Stromal TumorCharlotte M Brinch, Estrid Hogdall, Pieter DE Heer, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 2, 2021
Assessment of sarcopenia in patients with upper gastrointestinal tumors: Prevalence and agreement between computed tomography and dual-energy x-ray absorptiometryCasper Simonsen, Thomas S Kristensen, Anna Sundberg, et al.
Cancer Chemotherapy and Pharmacology|February 6, 2008
Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancerPieter de Heer, Maro H Sandel, Gunther Guertens, et al.
Acta Oncologica (Stockholm, Sweden)|January 31, 2019
Exercise-mediated improvement of depression in patients with gastro-esophageal junction cancer is linked to kynurenine metabolismAnita Herrstedt, Marie L Bay, Casper Simonsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancerMichiel F G de Maat, Cornelis J H van de Velde, Naoyuki Umetani, et al.
The Lancet Regional Health. Europe|August 13, 2025
Nasogastric tube after oesophagectomy and risk of anastomotic leak: a Nordic, multicentre, open-label, randomised, controlled, non-inferiority trialJakob Hedberg, Joonas Kauppila, Eirik Kjus Aahlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Caspase-3 activity predicts local recurrence in rectal cancerPieter de Heer, Elza C de Bruin, Elma Klein-Kranenbarg, et al.
EJNMMI Research|June 6, 2025
Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancersRuben D Houvast, Vincent Q Sier, Maurice van Duijvenvoorde, et al.
Clinical Nutrition ESPEN|January 14, 2024
The impact of high versus standard enteral protein provision on functional recovery following intensive care admission: Protocol for a pre-planned secondary Bayesian analysis of the PRECISe trialSamuel Heuts, Pieter de Heer, Andrea Gabrio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2007
Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapyPieter de Heer, Marleen J E M Gosens, Elza C de Bruin, et al.
Pageof 2